Q4 2024 Earnings Call Transcript February 10, 2025 Vertex Pharmaceuticals Incorporated misses on earnings expectations. Reported EPS is $3.98 EPS, expectations were $4.02. Operator: Good day, and ...
5h
Zacks.com on MSNVRTX's Q4 Earnings Miss Mark, Revenues Beat on Higher Product SalesVertex Pharmaceuticals Incorporated VRTX reported adjusted earnings of $3.98 per share for the fourth quarter of 2024, ...
Researchers from Skoltech, prosthetics manufacturer Motorica, and Far Eastern Federal University have for the first time ...
A recent study in an animal model provides direct evidence for the role of the vagus nerve in gut microbiome-brain ...
Researchers at the Center for Life Sciences at the Paul Scherrer Institute PSI have for the first time identified structural ...
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
MAXONA Pharmaceuticals today announced that it has emerged from stealth with the completion of the U.S. Phase 1 clinical development program for the company's first to market product, MAX-001, as a ...
This eBook celebrates the achievements of inspiring women in life sciences, highlighting their journeys, challenges and ...
Your brain constantly juggles sensory information to make split-second decisions, but how? A new latent circuit model ...
4hon MSN
For decades, scientists across the globe have investigated methods to accurately measure drug permeability across the blood-brain barrier, a compact layer of cells that protect the brain from ...
Our main goal in neuroscience is advancing the understanding of the human nervous system and the mechanisms behind its disorders. However, many invasive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results